tirzepatide and cagrilintide together Novo Nordisk to initiate study assessing CagriSema vs difference between retatrutide and semaglutide
Description
He takes a deep dive into the famous weight loss drug, Semaglutide.
In New England Journal of Medicine (NEJM) Wharton S, et al.N Engl J Med
The science and data is undeniable
IQVIA notes six big shifts in medicines use in 2023: Growing use of immunology treatments up 60% from 2019 with treatment of Crohns disease and psoriasis up 26% and 15%, respectively Rising use of novel obesity drugs which is the GLP-1 story Ill relate to the next graphic, below
Many clinicians and fitness professionals advocate for its potential to enhance fat metabolism, increase energy, and support overall weight management
With a safety profile consistent with existing treatments, experts see it as a breakthrough for patients preferring oral options.
